A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Hoag Hospital Clinical Study Demonstrates Luna Reduces Post-surgical Rehab Costs by 52%

In a groundbreaking study, Hoag Hospital, a leading not-for-profit regional health care delivery network in Orange County, California, presented the results of a two-year analysis at the 2023 American Association of Orthopedic Executives (AAOE) conference. The study demonstrated that the Luna in-home outpatient physical therapy care model reduces costs by 52% compared with traditional home health for total knee and hip replacements.

Hoag Orthopedic Institute conducted the study between 2021 and 2023 in collaboration with Luna, the leading provider of in-home outpatient physical therapy, to create a scalable solution aimed at reducing per episode care costs through the use of in-home outpatient physical therapy in lieu of traditional home health services. The complete study can be viewed here.

As healthcare spending continues to rise, the American Academy of Orthopaedic Surgeons forecast a substantial increase in total knee replacement or total hip replacement surgery, with projected growth rates of up to 171% and 189% respectively (source) by 2030.

The Hoag Orthopedic Institute study showed that with the Luna care model, participating surgeons reduced their home health utilization by 86%, resulting in decreased blended costs of $2,517 per case. Patient outcomes also improved as readmission rates were reduced by 28%, compared with patients that received the traditional home health option.

Patients also demonstrated clinically important changes in pain and patient-specific functional scale scores of 66% and 76% respectively, and rated Luna with a world-class net promoter score of 89.

“Luna’s care model is cost-effective and leads to better patient outcomes when compared with traditional home health, and is revolutionizing healthcare delivery nationwide. By making high-quality care more accessible to patients, Luna can provide postoperative total hip replacement and total knee replacement patients with a more efficient alternative to traditional home health services,” said Palak Shah, Co-Founder and Head of Clinical Operations at Luna.

At Hoag, overutilization of home health visits was also a challenge, with patients utilizing an average of eight visits of home health prior to continuing care at an outpatient facility. While a typical course of care at Luna consists of completing the entire care plan with a Luna therapist (all billed under outpatient rates, and delivered to the home), Hoag had patients complete the initial four to six treatment sessions with Luna prior to transitioning to an outpatient facility.

Patients completed four visits for total hip replacements and six visits for total knee replacements with the Luna therapist. During care at Luna, patients were monitored for visit utilization, post-surgical complications, readmissions, and adverse outcomes.

Innovative healthcare organizations are exploring cost-effective ways of delivering care while continuing to improve patient outcomes, and, to date, Luna has collaborated with Providence, Emory Healthcare, Intermountain Healthcare, UCLA Health and Scripps Health, among others.

Luna currently operates across 48 markets in 27 states, and has treated 35,000+ patients in their homes. In 2022, Luna became the fastest growing physical therapy clinic nationally with 6,183 percent growth in visits during the four consecutive years since it was founded in 2018. This is higher than any reported growth during the same time frame from any physical therapy clinic group.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy